Associations - CDH1 (Cadherin 1)

CDH1 expression	Pancreatic Adenocarcinoma	CDH1 expression	Pancreatic Adenocarcinoma	erlotinib + selumetinib Sensitive: C3 – Early Trials erlotinib + selumetinib Sensitive : C3	erlotinib + selumetinib Sensitive: C3 – Early Trials erlotinib + selumetinib Sensitive : C3
CDH1 mutation	Breast Cancer	CDH1 mutation	Breast Cancer	paclitaxel + epirubicin Resistant: C3 – Early Trials paclitaxel + epirubicin Resistant : C3	paclitaxel + epirubicin Resistant: C3 – Early Trials paclitaxel + epirubicin Resistant : C3
CDH1 mutation	Breast Cancer	CDH1 mutation	Breast Cancer	paclitaxel Resistant: C3 – Early Trials paclitaxel Resistant : C3	paclitaxel Resistant: C3 – Early Trials paclitaxel Resistant : C3
CDH1 mutation	Gastric Cancer	CDH1 mutation	Gastric Cancer	cetuximab Resistant: D – Preclinical cetuximab Resistant : D	cetuximab Resistant: D – Preclinical cetuximab Resistant : D
CDH1 expression	Non Small Cell Lung Cancer	CDH1 expression	Non Small Cell Lung Cancer	NBL-001 Resistant: D – Preclinical NBL-001 Resistant : D	NBL-001 Resistant: D – Preclinical NBL-001 Resistant : D
CDH1 overexpression	Small Cell Lung Cancer	CDH1 overexpression	Small Cell Lung Cancer	AZD2811 Resistant: D – Preclinical AZD2811 Resistant : D	AZD2811 Resistant: D – Preclinical AZD2811 Resistant : D
CDH1 expression	Colon Cancer	CDH1 expression	Colon Cancer	Hakin-1 Sensitive: D – Preclinical Hakin-1 Sensitive : D	Hakin-1 Sensitive: D – Preclinical Hakin-1 Sensitive : D
CDH1 deletion	Breast Cancer	CDH1 deletion	Breast Cancer	vorinostat Sensitive: D – Preclinical vorinostat Sensitive : D	vorinostat Sensitive: D – Preclinical vorinostat Sensitive : D
CDH1 deletion	Breast Cancer	CDH1 deletion	Breast Cancer	MGCD0103 Sensitive: D – Preclinical MGCD0103 Sensitive : D	MGCD0103 Sensitive: D – Preclinical MGCD0103 Sensitive : D
CDH1 deletion	Breast Cancer	CDH1 deletion	Breast Cancer	SB939 Sensitive: D – Preclinical SB939 Sensitive : D	SB939 Sensitive: D – Preclinical SB939 Sensitive : D
CDH1 deletion	Breast Cancer	CDH1 deletion	Breast Cancer	entinostat Sensitive: D – Preclinical entinostat Sensitive : D	entinostat Sensitive: D – Preclinical entinostat Sensitive : D
CDH1 deletion	Gastric Cancer	CDH1 deletion	Gastric Cancer	vorinostat Sensitive: D – Preclinical vorinostat Sensitive : D	vorinostat Sensitive: D – Preclinical vorinostat Sensitive : D

CDH1 (Cadherin 1)

Associations(15)

Associations
(15)